Your browser version may not work well with NCBI's Web applications. More information here...
1: Nat Clin Pract Gastroenterol Hepatol. 2006 Apr;3(4):229-33; quiz following 233.Click here to read Links

A patient with anemia of obscure origin: Crohn's disease in disguise.

Dubcenco E, Jeejeebhoy KN, Streutker CJ, Zalev AH, Garvey MB, Kim YI, Baker JP.

Department of Medicine, University of Toronto and St Michael's Hospital, Toronto, ON, Canada.

BACKGROUND: A 65-year-old white Mediterranean male with a 10-year history of intermittent anemia, who was otherwise completely asymptomatic, was referred to our hospital in March 2004. He had a medical history of beta thalassemia and fecal occult blood tests had occasionally been positive. INVESTIGATIONS: Fecal occult blood test, laboratory investigations, esophagogastroduodenoscopy, colonoscopy with retrograde ileoscopy, mesenteric angiography, small-bowel series, CT scan of the abdomen and pelvis, Meckel's scan, and capsule endoscopy. Laparoscopic surgery followed by macroscopic and microscopic histopathologic examination of samples obtained during the procedure. DIAGNOSIS: Crohn's disease of the small bowel. MANAGEMENT: Laparoscopic segmental small-bowel resection with end-to-end anastomosis. Postsurgical treatment with Pentasa 4 g a day.

PMID: 16582965 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Mesalamine (Asacol® , Canasa® , Pentasa® , ...)

    Mesalamine is used to treat ulcerative colitis (a condition in which part or all of the lining of the colon [large intestine] is swollen or worn away). Mesalamine delayed-release tablets and controlled-release capsules m...

  • Source: AHFS Consumer Medication Information